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Vascular aging is associated with structural and functional modiﬁcations of the arteries, and by an in-
crease in arterial wall thickening in the intima and the media, mainly resulting from structural mod-
iﬁcations of the extracellular matrix (ECM) components. Among the factors known to accumulate with
aging, advanced lipid peroxidation end products (ALEs) are a hallmark of oxidative stress-associated
diseases such as atherosclerosis. Aldehydes generated from the peroxidation of polyunsaturated fatty
acids (PUFA), (4-hydroxynonenal, malondialdehyde, acrolein), form adducts on cellular proteins, leading
to a progressive protein dysfunction with consequences in the pathophysiology of vascular aging. The
contribution of these aldehydes to ECM modiﬁcation is not known. This study was carried out to in-
vestigate whether aldehyde-adducts are detected in the intima and media in human aorta, whether their
level is increased in vascular aging, and whether elastin ﬁbers are a target of aldehyde-adduct formation.
Immunohistological and confocal immunoﬂuorescence studies indicate that 4-HNE-histidine-adducts
accumulate in an age-related manner in the intima, media and adventitia layers of human aortas, and are
mainly expressed in smooth muscle cells. In contrast, even if the structure of elastin ﬁber is strongly
altered in the aged vessels, our results show that elastin is not or very poorly modiﬁed by 4-HNE. These
data indicate a complex role for lipid peroxidation and in particular for 4-HNE in elastin homeostasis, in
the vascular wall remodeling during aging and atherosclerosis development.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Aging is the largest known risk factor for most human diseases
[1–4]. The aging process generates a progressive loss of biological
functions and abilities to manage metabolic changes, with parti-
cular impact on the development of cardiovascular diseases [5,6],
which represent the major cause of morbidity and mortality in
aged people [7,8]. It is very important to understand the physio-
logical mechanisms involved in the natural process of aging, to
develop new prevention, diagnosis and treatment approaches,
allowing to slow down the onset of aging consequences.B.V. This is an open access article
advanced lipoxidation end
M, extracellular matrix;
cells
c Institute, Bijenicka 54, HR-In normal arteries, the proteins of the extracellular matrix
(ECM) (collagen, elastin, ﬁbrillin, glycoproteins and proteoglycans)
produced by smooth muscle cells (SMC) ensure the stability, re-
silience, and compliance of arteries [9]. Collagen and elastin, two
major scaffolding ECM proteins provide structural integrity and
elasticity to the vessels, allowing them to stretch while retaining
their ability to return to their original shape when the pressure is
over. Vascular aging is most of the time associated with structural
and functional modiﬁcations of the arteries, even in healthy el-
derly, and particularly by an increase in arterial wall thickening in
the intima and the media, mainly resulting from the accumulation
and structural modiﬁcation of ECM components and a dis-
organization of SMC [10,11]. Increased expression of matrix me-
talloproteases, (MMP-2, MMP-1, MMP-9), as well as the decreased
expression of tissue inhibitors of MMPs (TIMPs) contribute to the
fragmentation of elastic ﬁbers [12,13]. Increased collagen deposi-
tion and reduction of elastin content due to elastin ﬁber de-
gradation, often associated with vascular calciﬁcations, contributeunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Atherosclerosis grade
0
1
2
A
th
er
os
cl
er
os
is
 g
ra
de
 (a
rb
it.
 u
ni
t)
32
-5
9 
60
-7
5 
76
-9
1 
3
4
5
Men
0
1
2
A
th
er
os
cl
er
os
is
 g
ra
de
 (a
rb
it.
 u
ni
t)
32
-5
9 
60
-7
5 
76
-9
1 
3
4
5
Women
Age group 
Fig. 1. Age- and sex-related atherosclerosis grade of the different subjects. 59
subjects were analyzed, 29 men and 30 women, each divided in three groups,
group I (32–59 year-old), group II (60–75 year-old), group III (76–91 year-old). The
results are presented as function of the atherosclerotic grade, classiﬁed from 1 to
5 as described in the Materials and Methods section. Statistical analysis was per-
formed using one-way ANOVA followed by Holm-Sidak test, group I being com-
pared to group II and III (SigmaStat software). Comparison group II to group III was
not signiﬁcant. Mean 7 SEM are indicated by the doted line. n p o 0.05.
K. Zarkovic et al. / Redox Biology 4 (2015) 109–117110to the development of arterial stiffening [5].
Arterial stiffness is characterized by structural and functional
alterations of the intrinsic elastic properties of the arteries and an
increased resistance to vessel deformation, resulting from a de-
crease in artery elasticity (compliance) and an increase in pulse
wave velocity (pwv) [5,14], generating an increased systolic pres-
sure, with deleterious consequences on the heart, generating
cardiac hypertrophy and increased ventricular oxygen consump-
tion. Arterial stiffening is a hallmark of vascular aging, and a major
risk factor for the development of cardiovascular diseases, that can
be exacerbated by diabetes, hypertension or atherosclerosis. It is a
direct cause of ventricular hypertrophy, renal dysfunction and
stroke, independently of the other causes of vascular aging [15]. It
is an independent risk factor for cardiovascular diseases, which
may predispose to atherosclerosis, and vice-versa. The mechanisms
linking these two risk factors are not known [16] .
Arterial stiffness is aggravated by the presence of advanced
glycation-end products (AGEs), formed during glucose oxidation,
which slowly accumulate in normal aging, and are strongly in-
creased in diabetes [17,18]. AGEs form cross-links on ECM proteins
(on collagens; but also on elastin) [19,20], by reacting with their
lysine residues, which decreases their turnover and promotes ar-
terial stiffness and intima-media thickness [21]. These modiﬁca-
tions are implicated in the loss of vascular elasticity.
Though electrophilic carbonyl compounds derived from lipid
peroxidation play a major involvement in the modulation of life-
longevity [22], and the development of oxidative stress-associated
diseases such as atherosclerosis or neurodegenerative diseases
[23,24], it is not known so far whether and how these agents are
involved in the onset of vascular aging. Moreover, since arterial
stiffness and atherosclerosis are independent cardiovascular risk
factors, and are characteristic of vascular aging, it is difﬁcult to link
atherosclerosis and oxidized lipids to arterial stiffness develop-
ment [8,16]. Lipid peroxidation products accumulate with aging,
due to a reduction in antioxidant defenses and increased oxidative
stress [25–27]). Aldehydes generated from the peroxidation of
polyunsaturated fatty acids (PUFA), particularly 4-hydroxynonenal
(4-HNE), malondialdehyde (MDA), acrolein, share several proper-
ties with AGEs, as they form adducts on cellular proteins, parti-
cularly on histidine and cystein (4-HNE) or lysine (acrolein),
leading to a progressive protein dysfunction with consequences in
the pathophysiology of vascular aging [24]. As a consequence,
detoxiﬁcation mechanisms, including the removal of electrophiles
by glutathione transferase-catalyzed conjugation, are considered
as major longevity assurance mechanisms [22]. It is not known
whether aldehydes accumulate on ECM proteins (elastin or col-
lagen), and contribute to elastin aging and arterial stiffness.
However the formation of 4-HNE adducts on elastin has been re-
ported in the dermis in human patients affected with actinic
elastosis, suggesting that 4-HNE generated by UVA and UVB from
solar radiations, is able to modify elastin in the skin [28].
The objectives of this study were to investigate whether alde-
hyde-adducts are detected in the intima, media and adventitia in
human aorta, whether their level is increased as function of aging,
and whether elastin ﬁbers are a target of aldehyde-adduct for-
mation. Immunohistological and confocal immunoﬂuorescence
studies indicate that 4-HNE-adducts accumulate in aged aortas,
mainly on SMC. In contrast, even if the structure of elastin ﬁber is
strongly altered in aged vessels, our results show that elastin is not
or very poorly modiﬁed by 4-HNE. These data do not rule out a
role for lipid peroxidation in the metabolism (degradation, lack of
renewal) of elastin in the vascular wall.Material and methods
Aortas recovery
The material for the study consisted of 59 human abdominal
aorta specimens removed by autopsy from patients who died at
the age comprised between 32 and 91 years (average 71 year-old),
out of which 30 were women and 29 men. None of the deceased
persons suffered from any type of connective tissue disorder, 30
were hypertensive, 31 diabetic and 17 smokers. Specimen of aorta
of the 3 year-old child was taken as a healthy control sample in the
study.
The autopsies were performed within 6–10 h after death in the
Department of Pathology, Clinical Hospital, Zagreb. Aorta tissue
was grossly inspected, cut by consecutive sections into slabs of
about 5 mm thickness and ﬁxed in 10% formalin. Upon ﬁxation the
aorta tissues were dehydrated in graded ethanol and embedded in
parafﬁn.
Immunohistochemistry
Formaldehyde-ﬁxed aorta segments embedded in parafﬁnwere
cut into 10 mm sections. Monoclonal antibodies that detect 4-HNE-
modiﬁed proteins were obtained from culture medium of clone
“HNE g4” which was derived from a fusion of S2-Ag8 myeloma
cells with B-cells of a BALBc mouse immunized with 4-HNE
modiﬁed keyhole limpet hemocyanin [29]. The antibody is speciﬁc
for the HNE-histidine epitope in HNE-protein conjugate. 4-HNE-
lysine and 4-HNE-cysteine give 5% and 4% cross-reactivity with
HNE Ig4. Immunohistochemical detection of 4-HNE adducts was
done using the Envision System (Dako, Denmark), with contrast
staining using hematoxylin and Masson’s trichrome. Positive re-
action to HNE was stained by 3, 3-diaminobenzidine tetrachloride
(DAB, Dako, Denmark), and pale red positive elastin staining with
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Fig. 2. Accumulation of HNE-adducts in human aortas. Aortic sections were labeled with an anti-histidine adduct antibody and revealed by a peroxidase-conjugated
secondary antibody, as described in the Material and Methods section. The intensity of HNE reaction was semi-quantitatively evaluated in SMC, as 0 (negative), 1 (low, less
than 10% of 4-HNE-positive SMC), 2 (moderated, 10–30%), 3 (more than 30%). The results are presented as mean of HNE staining intensity in all 59 subjects (men þ women)
divided in the three groups as deﬁned in Fig. 1: Age group I: 32–60 year-old, 13 subjects; Age group II: 60–75 year-old, 19 subjects; Age-group III: 75–91 year-old, 27 subjects.
The three aortic layers (intima, media and adventitia), were analyzed for each subject. Statistical analysis was performed using one-way ANOVA followed by Holm-Sidak test,
group I being compared to group II and III (SigmaStat software). Comparison group II to group III was not signiﬁcant. Mean 7 SEM are indicated by the doted line.
n p o 0.05.
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lationship of immunohistochemical positive reactions with elastin
[30].
Stained sections were analyzed qualitatively and semi-quanti-
tatively on Olympus 40 light microscope. Immunohistochemical
staining to 4-HNE were analyzed in the three aorta layers for each
vessel specimen. The immunohistochemical 4-HNE staining was
graded mainly in SMC, as follows: 0  entirely negative, (though
some SMC can be positive), 1- low positive in sporadic SMC; 2 –
moderately positive in 10–30% SMC and 3-4-HNE im-
munopositivity present in more than 30% of SMC.
Immunoﬂuorescence and confocal microscopy
Aorta sections were stained with the rabbit polyclonal anti
4-HNE-Michael adduct (Calbiochem) and mouse monoclonal anti-
human elastin antibodies, alexa-Fluor 488 (green)- and Alexa-
Fluor 546 (red)-conjugated secondary antibody were from Mole-
cular Probes (Invitrogen, Cergy-Pontoise, France). The slides were
visualized using a Zeiss LSM 510 ﬂuorescence confocal microscope
(Le Pecq, France). Picture analysis was done using ImageJ 1.49j
software.
Atherosclerotic grade quantiﬁcation
Atherosclerotic lesions in intima of aorta were analyzed on
hematoxylin eosin stained slices. Intimal lesions in aorta were
classiﬁed in the following subgrades:
1.Initial lesions.
1a.Fatty streak with accumulation of intracellular (macro-
phages and smooth muscle cells) and extracellular lipid in in-
tima of aorta.
1b.Intimal cell mass containing smooth muscle cells andconnective tissue but not lipid (“cushions”).
2.Characteristic atherosclerotic ﬁbro-fatty plaque consisting of
two morphologic components:
2a.The ﬁbrous cap of thick ﬁbrous connective tissue with foamy
macrophages and smooth muscle cells covered by intact
endothelium.
2b.Atheroma-necrotic mass of lipids that forms the middle part
of the lesion with ﬁbrous cap over it and the loss of endothelial
continuity combined with inﬁltration of inﬂammatory mono-
cytes and activated T lymphocytes.
3.Complicated atherosclerotic lesions: Thrombosis on and
within the ﬁbrous cap. Neovascularization of the cap.
4.Thinning of the underlying tunica media. Calciﬁcation within
the atheroma and ﬁbrous cap.
5.All type 3/4 complications plus ulceration of the ﬁbrous cap.
Statistical analyses
Estimates of statistical signiﬁcance were performed by t-test or
analysis of variance followed by multiple comparison procedure
(using the SigmaStat 3.5, Systat software). Tests for normality and
equal variance were performed by the Kolmogorov–Smirnov test.
Differences between means values were evaluated by unpaired t
test, to compare two groups, or by one-way ANOVA to compare
group I vs the other groups, by the Holm-Sidak test. Values of
p o 0.05 were considered signiﬁcant.Results
Accumulation of 4-HNE-adducts in the vessels
We ﬁrst checked whether 4-HNE adducts accumulate in an
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Fig. 3. Comparison of HNE-adducts and elastin in young and old aortas. Characterization of aortas from two subjects aged 3 and 83 year-old respectively. Each aorta was
characterized by Masson trichrome which stains collagen and elastin (A,B), orcein, which is speciﬁc of elastin and elastic tissues (C,D), and 4-HNE adducts (E,F). -Masson
trichrome: aorta of the 3 year-old child (left) shows a pattern of normal, parallel elastic, gentle ﬁbers that are light-red stained, while the aorta of 83 year-old man (right)
shows thin, fragmented elastic ﬁbers embedded in abundant connective tissue that separates and disrupts parallel order of elastic ﬁbers (Masson’s trichrome, 200 ).
-Orcein: aorta of the 3 year-old child (left) shows “parallel”, densely arranged elastic ﬁbers, while the aorta of 83 year-old man shows broken, separated and disorganized
elastic ﬁbers, without the “parallel” arrangement (orcein 200 ).-4-HNE: in the aorta of the 3 year-old child (left) immunohistochemical reaction to 4-HNE shows the
absence of 4-HNE in elastic ﬁbers, in SMC and in connective tissue, while in the aorta of 83 year-old man (right) the 4-HNE immunopositivity appeared in SMC, but not in
elastic ﬁbers (4-HNE, 200 ).
K. Zarkovic et al. / Redox Biology 4 (2015) 109–117112
3-year-old child 83-year-old man
M
as
so
n 
tr
ic
hr
om
e/
SM
A
Fig. 4. High magniﬁcation of Masson trichrome/SMA staining in very young and very old aortic media. Aorta of the 3 year-old child (left) shows a parallel and dense
distribution of SMC between elastic ﬁbers. In the aorta of 83 year-old man (right), there is a reduced number of SMC and thick sporadic elastic ﬁbers in an abundant
connective tissue (SMA with Masson’s trichrome contrast staining, 400 ).
83
-y
ea
r-o
ld
 tu
ni
ca
 m
ed
ia
Masson trichrome orcein
Fig. 5. Thin and spaced elastic ﬁbers in old tunica media. Tunica media of the aorta of 83-years old man shows a thin and spaced elastic ﬁbers in the tissue stained by
trichrome Masson’s method (left), while in tissue stained by orcein (right) elastic ﬁbers look ticker (400 ).
K. Zarkovic et al. / Redox Biology 4 (2015) 109–117 113age-dependent manner in human aortas. Three groups were de-
ﬁned, group I, aged 32–59 years, group II, aged 60–75 years, group
III, aged 76–91 years. The characteristics of each group are de-
scribed in the Materials and Methods section. The atherosclerosis
grade was deﬁned for each group, between men and women, andthough the study was carried out on a small number of subjects,
the data reported in Fig. 1, conﬁrm the prevalence of the age-re-
lated atherosclerotic lesion development, and the increased
atherosclerotic grade in men vs women, signiﬁcant at least for the
group I vs group II or vs group III. Noteworthy, hypertensive
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Fig. 6. High magniﬁcation of Masson trichrome/HNE staining in old tunica media.
Aortic media of an 83-year-old man with positive immunochemical reaction to
4-HNE in smooth muscle cells (darker brownish color), but not in elastic ﬁbers and
connective tissue (4-HNE with Masson’s trichrome contrast staining, 400 ).
K. Zarkovic et al. / Redox Biology 4 (2015) 109–117114patients had high grade lesions, i.e. complicated atherosclerotic
lesions, while in normotensive patients, atherosclerosis was
mostly represented by characteristic atherosclerotic lesions, i.e.
ﬁbro-fatty plaques. These data are not shown, because most hy-
pertensive patients were more than 65 year-old, and the intensity
of the media staining by 4-HNE adducts was not signiﬁcantly
different from that of normotensive subjects.
Intimal thickening reﬂected the degree of atherosclerosis in all
samples, while thickness of the tunica media did not correlate
with the degree of atherosclerosis, age or even hypertension, in-
dicating primarily constitutional differences among people.
The expression of 4-HNE-adducts was semi-quantitatively
evaluated on all subjects and in each aortic layer, as shown in
Fig. 2. Our results indicate that the expression of 4-HNE adducts is
age-dependent, in each aortic layer. The differences are very
strong in the intima, due to the marked development of athero-
sclerotic lesions in very aged people (the most important group in
this study). As previously reported [23,24], 4-HNE expression is
increased in the lipid core of atherosclerotic lesions and at a lesser
extent in the ﬁbrous cap, mainly in SMC. The expression of 4-HNE
adducts is increased in the adventitia, probably associated with
vasa vasorum, which could play a role in the neovascularization of
atherosclerotic lesions as reported [31,32]. 4-HNE-adducts are
present in the media, though less marked than in the other two
layers. It is signiﬁcantly age-dependent and mainly associated with
SMC, which represent a main source of 4-HNE in this layer.
Elastin is not modiﬁed by HNE-adducts in human aortas
Our data indicate that, as expected, the structure of elastin is
deeply modiﬁed in an age-related manner. As illustrated in Fig. 3,
and at higher magniﬁcation in Figs. 4 and 5, orcein and Masson
trichrome staining point out an age-related increase of the in-
tralamellar space between elastic ﬁbers in the lamina elastica and
the media by comparison with the aorta from a very young child
(Fig. 4). This increased interlamellar space is primarily caused by
the formation of connective tissue between the elastic lamina, due
to the loss of elastic ﬁbers and SMC, as illustrated by the Masson
trichrome/SMA staining in the Fig. 4 that points out the strong
difference between young and very old media structure.
It should be mentioned that within a same aorta, in particular
in elderly persons, various types of histopathological changes oc-
curred simultaneously and were often of various degree, reﬂecting
the chronic character of atherosclerosis. Thickening of elastic ﬁbersappeared as black-thickened aggregates of ﬁbers (Figs 4 and 5).
Such ﬁndings are very often related to the ﬁndings of the atte-
nuated, spaced and fragmented thin elastic ﬁbers of lamina elas-
tica and tunica media in histological slides stained by Masson’s
trichrome technique. The thickened appearance of the orcein-
stained elastic ﬁbers probably reﬂected the modiﬁed elastoid
substance on the surface of elastic ﬁbers.
4-HNE-adduct expression in the media was present in SMC in
the expanded intralamellar area (Figs. 3 and 6). No 4-HNE adducts
were detected on elastin ﬁbers and in the connective tissue sur-
rounding the elastic ﬁbers (Fig. 6). The intensity of 4-HNE staining
was correlated with aging, as shown in the Fig. 2.
Immunoﬂuorescence and confocal studies conﬁrmed the lack
of co-localization between 4-HNE-adducts and elastin (Fig. 7). The
co-localization of elastin and 4-HNE adducts was studied in the
aortas of two patients aged 52 and 90 year old respectively, using
an anti Michael-adduct antibody (Calbiochem), which recognizes
several 4-HNE epitopes namely histidine-, cysteine- and lysine-4-
HNE adducts. Analysis of the results using the Image J129j soft-
ware, conﬁrmed the accumulation of 4-HNE adducts in the media,
and the age-dependent alterations of elastin structure. Moreover,
these data conﬁrmed that 4-HNE does not form adducts on aortic
elastin, since no or very slight co-localization was observed under
confocal microscopy and analysis of the merged pictures.
Altogether, these results emphasize the age-related accumula-
tion of 4-HNE-adducts in human aortas, and indicate that arterial
elastin is not a direct target of 4-HNE in the media, in contrast to
AGEs [19,20]. These results do not rule out a role for 4-HNE in
elastin alterations and loss occurring in aged arteries.Discussion
The aim of this study was to check whether age-related elastin
modiﬁcations observed in human aortas are correlated with an
increased accumulation of HNE-adducts (as a marker of lipid
peroxidation that increases in aged human tissues), and whether
elastin is modiﬁed by 4-HNE in human vessels. Our results indicate
that HNE-adducts accumulate in human aorta in an age-related
manner, mainly in the intima and the adventitia, and at a lesser
extent in the media. 4-HNE-adducts are mainly cellular, and are
not detected on elastin, even in elderly, indicating that elastin is
not a target of ALEs in the vascular wall. Interestingly, in some
patients, the presence of elastic tissue stained black with orcein,
but not recognized by other elastin probes, pointed out the accu-
mulation of an elastoid material, comparable to the elastotic ma-
terial which accumulates in the skin, in the onset of actinic elas-
tosis development.
The ﬁrst observation is that 4-HNE-adducts are detected in human
aortas and their content increases with age, in agreement with the
fact that causal links between PUFA levels, 4-HNE adduct formation
and longer lifespan have been established and discussed [22]. Im-
portantly, 4-HNE adducts are present in SMC in the aortas of young
patients (less than 35 years old, no atherosclerosis development),
even in a very young (3 year-old) child. 4-HNE is rapidly generated
from PUFA oxidation, under various physiological and pathological
situations, independently of aging [33,34]. A dual role has been re-
ported for 4-HNE, at least in vitro on cultured cells, where low in-
tracellular concentrations (0.1–5 mM), could promote ‘hormesis’,, i.e.
protection via exposure to low stressor concentrations, characterized
by increased antioxidant defenses, and survival cellular responses
such as cell migration, angiogenesis, proliferation or autophagy
[35,36], while higher concentrations are proinﬂammatory and proa-
poptotic [34,37]. Noteworthy, the post-translational modiﬁcations of
proteins elicited by 4-HNE, lead ﬁrst to a gain of function which
modulates cell signaling [38–40]. Thus it can be expected that the
Magnification x40 Confocal 780
Absence of co-localisation 4-HNE adducts and elastin in aorta
4-HNE adducts
elastin
4-HNE adducts
elastin
S1 – 52 year-old
S2 – 90 year-old
Fig. 7. 4-HNE adducts and elastin do not colocalize in human aortas. Immunoﬂuorescence and confocal microscopy were done on aortas recovered from two female subjects
aged 52 year-old and 90 year-old respectively. Formaldehyde-ﬁxed aorta segments were labeled with anti-4-HNE Michael adduct polyclonal (Calbiochem), and anti-elastin
monoclonal antibody (Santa Cruz), and with secondary antibodies Alexa Fluor 488 anti mouse and Alexa Fluor 546 anti-rabbit IgG from Molecular Probes (Invitrogen), as
described in the Material/Methods section. The confocal composite image (merge) ( 40 magniﬁcation), was analyzed using ImageJ 1.49j software, and conﬁrmed the lack of
co-localization between elastin (green peaks) and 4-HNE adducts (red peaks). These data are representative of 4 separate experiments.
K. Zarkovic et al. / Redox Biology 4 (2015) 109–117 115presence of 4-HNE in youngers is a marker of transient oxidative
stress, which could be considered as a defense mechanism to provoke
cell survival, proliferation and compensatory signalings. On the other
hand, it is likely that detoxifying enzymes (glutathione S-transferases,
aldose reductase, aldehyde dehydrogenases) and the proteasome
system [41] are fully efﬁcient at controlling the 4-HNE concentration
in youngers, and its removal from the environment once formed,
whereas in elderly, these systems are less active and 4-HNE adducts
accumulate on proteins, causing dysfunction and apoptosis.
The accumulation of 4-HNE-adducts is very high in the intimal
aorta, mainly in older patients with high atherosclerosis grade.
These data were expected since oxidized LDL and lipids accumu-
late in the intima in the early lesions and in the lipid core of ad-
vanced atherosclerotic lesions [23,24]. These data conﬁrm that
4-HNE is a main marker of oxidative stress and LDL oxidation
which could contribute to the evolution of the lesions via its abilityto modify proteins and generate cell dysfunction. 4-HNE expres-
sion was also increased in the adventitia of the elderly, probably
associated with the vasa vasorum, which are involved in the
supplying of nutrients and oxygen to atherosclerotic lesions, and
the development of angiogenesis in the atherosclerotic plaque
[32,42]. The recently reported angiogenic effect of 4-HNE suggests
a role for this aldehyde in the development of vasa vasorum and
microcapillaries in atherosclerotic plaque [35,43]. Noteworthy, we
did not detect any difference in HNE-adduct staining between
normotensive and hypertensive patients. However, this does not
rule out a role for hypertension in the generation of HNE, because
most hypertensive patients in this study were very old and pre-
sented high grade of atherosclerosis, which may minimize the
implication of hypertension in 4-HNE generation.
More generally, the expression of HNE-adducts in the media
was lower than in the intima and adventitia layers, and it was
K. Zarkovic et al. / Redox Biology 4 (2015) 109–117116mainly associated with SMC. Importantly, our data show that
aortic elastin is not modiﬁed by 4-HNE, even in the oldest patients
exhibiting evident features of elastin degradation and loss. These
data indicate that elastin in the aorta is not a target of 4-HNE, (nor
acrolein, data not shown), in contrast to AGEs which were de-
tected on elastin in diabetic patients [19,20]. These data also differ
from the results observed in human skin elastin, showing that
elastin and 4-HNE co-localize in actinic elastosis lesions [28].
Several hypothesis could be proposed explaining the fact that
4-HNE, though present, does not modify elastin. A ﬁrst hypothesis could be that histidine epitopes which are
the main target for 4-HNE, are present at a very low level on
aortic elastin [44], and are probably not available for mod-
iﬁcation by 4-HNE, in the aortic elastin structure. However,
immunoﬂuorescence and confocal studies which conﬁrmed the
lack of co-localization between elastin and 4-HNE, were per-
formed using an anti-Michael-adduct antibody, which re-
cognizes histidine, cysteine and lysine epitopes, this indicating
that 4-HNE does not bind any of its usual targets on elastin. Another possibility is that available lysine epitopes are already
modiﬁed by AGEs in oldest subjects, since the existence of AGE-
adducts has been reported on elastin [19,20]. This could also
explain why acrolein-adducts were not detected, since acro-
lein-adducts are mainly formed on lysine. However, it should
be noted that elastin protein is formed from its precursor tro-
poelastin, through a massive cross-linking of lysines catalyzed
by lysyl oxidase, which generates the mature insoluble and
stable elastin [45]. Thus it is likely that lysine epitopes are very
poorly available for aldehyde modiﬁcation in mature elastin in
the vessels.
Elastin is a long-life protein, which is not or very poorly re-
newed, even in case of elastin loss, and particularly in the vessel.
Interestingly, we recently reported that 4-HNE inhibits tropoelas-
tin synthesis in ﬁbroblasts, by forming adducts on the EGF re-
ceptor, which stimulates EGFR signaling, this counteracting the
elastogenic activity of TGF-β [46]. Moreover, 4-HNE could increase
the expression of metalloproteases, thereby contributing to elastin
degradation [47,48]. Thus it can be hypothesized that 4-HNE, even
if it does not directly modify elastin, contributes to its degradation,
and to impair its potential renewal [46].
It is to note that elastin in the skin could be modiﬁed by 4-HNE
as reported by Tanaka et al. [28] in actinic elastosis lesions in
humans. In agreement with these data, our preliminary results
indicate that acrolein-adducts are present on elastin in human
skin, in contrast with aorta (data not shown). The mechanisms
involved in skin elastin modiﬁcation are not so far identiﬁed, nor
the structure of modiﬁed elastin (intact elastin, fragments, tro-
poelastin…). AGEs such as Nε-(carboxymethyl)lysines also modify
skin elastin, rendering it less digestible for leukocyte elastase, a
mechanism probably involved (at least in part), in the accumula-
tion of elastotic material [49]. Preliminary results in our group,
indicate that elastin can be in vitro modiﬁed by acrolein and
4-HNE, which progressively inhibits its degradation by elastase. So,
the fact that elastin in aorta is not modiﬁed by lipid oxidation
products means that aortic and skin elastin do not share exactly
the same structure, or that elastin epitopes that could be modiﬁed
by aldehydes in the skin, are not formed in aortas, or that the
modiﬁcation of elastin in the skin occurs on tropoelastin, since a
neosynthesis of elastin could be involved in the accumulation of
elastotic material in the onset of photoaging [50]. Noteworthy, the
presence of “elastoid” material was observed in the aortas of old
subjects, pointing out similarities between skin and vascular
elastin aging, though no direct modiﬁcation of elastin by 4-HNE
was observed in this study. Further studies will be necessary foridentifying the mechanism of elastin aging in arteries and the
targets and role of 4-HNE in this process.Acknowledgements
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